Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 57, 2020
Previous Article Next Article

LMCT transition-based red-light photochemotherapy using a tumour-selective ferrocenyl iron(iii) coumarin conjugate

Author affiliations

Abstract

A rationally designed iron(III) complex (2a) with pendant ferrocene and naturally occurring coumarin (esculetin) shows LMCT transition-based mitochondria-targeted red-light (600–720 nm) induced apoptotic toxicity against cancer cells but remains innocuous in the dark and to normal cells.

Graphical abstract: LMCT transition-based red-light photochemotherapy using a tumour-selective ferrocenyl iron(iii) coumarin conjugate

Back to tab navigation

Supplementary files

Article information


Submitted
05 May 2020
Accepted
29 May 2020
First published
15 Jun 2020

Chem. Commun., 2020,56, 7981-7984
Article type
Communication

LMCT transition-based red-light photochemotherapy using a tumour-selective ferrocenyl iron(III) coumarin conjugate

T. Sarkar, A. Bhattacharyya, S. Banerjee and A. Hussain, Chem. Commun., 2020, 56, 7981
DOI: 10.1039/D0CC03240A

Social activity

Search articles by author

Spotlight

Advertisements